Scripps Research Leverages Advanced Data Solutions to Enhance Structural Biology and Vaccine Research
Scripps Research, founded in 1924, is one of the leading nonprofit research institutions in the world, specializing in biomedical sciences. The Ward Lab at Scripps Research focuses on cryo-electron microscopy (cryo-EM) and structural biology, studying virology and immunology to advance vaccine and therapeutic developments. However, with the rapid expansion of cryo-EM capabilities, the lab faced significant challenges in managing the exponential growth of data. By implementing a high-performance data intelligence platform, Scripps Research optimized data storage, accessibility, and processing, leading to faster research outcomes and groundbreaking discoveries in vaccine development.
Challenges
- Data Explosion from Advanced Imaging: The advent of direct electron detectors and high-resolution cameras led to a massive surge in data generation, overwhelming existing infrastructure.
- Need for High Availability and Accessibility: Scientists required a platform with seamless access to real-time data from anywhere, ensuring uninterrupted research workflows.
- Complexity of Data Processing and Workflow Management: The manual nature of cryo-EM data processing slowed down critical scientific insights and experiment iterations.
Solution
Scalable High-Performance Data Platform
A robust infrastructure was built to handle real-time data ingestion, storage, and processing, enabling 24/7 research activities.
Seamless Access and Uptime
The platform provided high availability and ensured researchers could interact with their data effortlessly from anywhere.
Accelerated AI and HPC Integration
Advanced AI and GPU computing streamlined protein modeling, significantly reducing the time required for structural analysis and drug discovery.
Use Cases
- Real-Time Cryo-EM Data Streaming: Data streams directly from advanced electron microscopes, enabling immediate analysis and reducing experiment cycles.
- AI-Accelerated Protein Design: Generative AI models assist in designing protein scaffolds faster, allowing scientists to iterate and validate vaccine candidates efficiently.
- Rapid Drug Targeting: AI tools help identify molecular pockets for drug design, accelerating early-stage therapeutic development.
- COVID-19 Vaccine Research: Knowledge from studying viruses like HIV and influenza was rapidly translated into COVID research to analyze immune response and stabilize vaccine proteins.
- Structural Biology for Immunology: Foundational research into viral antigens and immune system interactions informs vaccine and therapeutic design across various diseases.
Benefits
- Faster Scientific Discoveries: Researchers gained the ability to process data in real time, cutting down analysis timelines from months to days.
- Enhanced Research Productivity: Scientists could focus on research rather than infrastructure management, improving efficiency and collaboration.
- Revolutionized Vaccine Development: AI-driven modeling accelerated protein design, directly impacting vaccine and therapeutic advancements.
- Higher Research Throughput: Improved data handling capabilities enabled more experiments and iterations, leading to innovative discoveries.
QuoteHaving a high-performance data intelligence platform at your disposal allows you to spend more time on the research that you’re interested in. Our scientists are able to come here, log in, collect their data, process their data, and not have to worry about where it’s stored, whether it’s still going to be there the next week, or if they are running out of space.
Charles BowmanStaff Scientist, Ward Lab, Scripps Research
